Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
(photos of mammography devices)Skip Mammography NavigationMammography
Information for mammography facility personnel, inspectors, and consumers              
about the implementation of the Mammography Quality Standards Act of 1992 (MQSA)
(nagivation toolbar)
Home About Regulations Guidance Certification/Inspection Scorecard Reports Consumers Archives Contact Us

PDF Printer VersionMQSA INSPECTION PROCEDURES 6.03 – (8/1/07)

(Note: The sections in blue, which also begin with the ^+ symbol and end with the ^ - symbol, indicate notes, further details, clarifications, and guidance issues.)

1.      INTRODUCTION.. 10

1.1       ^+Further Details. 11

1.1.1   Inspection Kit 11

1.1.2   Laptop Failure during an Inspection. 11

1.1.3   Preventing Theft (ref. MQSA Document # 107) 11

1.1.4   Internet Access from the Laptop. 12

1.1.5   Noting Change within a Facility. 12

2.      GENERAL GUIDANCE.. 14

2.1       Advance Notice for Inspections. 14

2.1.1    .......................................... ^+Inspection Elements Common to Multiple Facilities. 14

2.1.2    ........ Routine Annual Facility Inspections - When should a facility be inspected?. 14

2.1.3    ................................................... Equipment Testing During an MQSA Inspection. 15

2.2       Getting Started. 16

2.2.1   ^+Identification Cards. 16

2.3       What to Do in Unusual Situations. 16

2.3.A         Operating without a Valid Certificate. 16

2.3.B         Conducting Mammography with an Unaccredited Machine. 17

2.3.1   ^+Expired Certificates Found During Inspections. 17

2.3.2   Facilities that Changed Status, Moved, Ceased Operations, or Closed. 18

2.4       When Certain Documents are Claimed but Unavailable for Review.. 23

2.4.1   ............................................................... ^+Claimed Items Use During Inspections. 23

2.5       Using the “Remarks” Sections. 23

2.5.1   ^+Remarks Section - What to Include. 24

2.5.2   Additional Information for Level 1 and Level 2 Noncompliances. 25

2.6       Facility Grouping for Inspection Fee Consolidation. 25

2.6.1   ^+Inspection Fees. 25

2.6.2   Inspection Fee Consolidation. 25

2.6.3   Billing Changes. 26

2.7       Repeat Observations. 26

2.8       Discussion of Inspection Observations with Facility Personnel (exit interview) 26

2.8.1   ^+Inspection Citation Levels. 27

2.8.2   Inspector Actions at the Facility after Completing the Inspection. 28

2.8.3   Facility Personnel Responsibility Re Inspection Observations Follow-Up. 28

2.8.4   Documentation and other Issues Related to Inspection Observations. 29

2.8.5   Inspection Findings Disputed by Facilities. 29

2.8.6   Inspection Errors Discovered by FDA or the State. 30

2.8.7   Recording State vs. MQSA Requirements. 31

2.8.8   Advice to a Facility Following a Serious Citation. 31

2.8.9   Advice to Facilities Regarding Corrective Actions. 32

2.8.10 Responding to FDA after Inspections (Letters with Inspection Report and Facility Comments) 32

2.8.11 Copying Records during Inspections and Using Remarks. 33

2.8.12 Veteran Health Administration (VHA) Inspections. 37

2.8.13 Corrected Before Inspection (CBI) Policy. 37

2.8.14 Facilities Comments Concerning Their Inspections. 38

3.      PRELIMINARY INFORMATION and DATA RECORDING.. 39

3.1       General 39

3.2       Data Recording. 39

3.2.1    Inspection Outline. 39

3.2.2    Equipment Registration. 42

3.2.3    Preliminary Facility and Inspection Information. 42

3.2.4    Facility Contacts. 44

3.2.5    X-ray System(s) Information. 45

3.2.6    Updating Pre-filled Data (Important) 48

3.3       ^+Further Details. 50

3.3.1   Facility Inspection Download (FISS Screen. 2.0 on your laptop) 50

3.3.2   Individuals Accompanying on Inspections. 50

3.3.3   Calibration Criteria for Densitometers and Sensitometers - Replacements. 51

3.3.4   EIN and CFN (FEI) 51

3.3.5   Additional Sites. 52

3.3.6   Post-Exposure Indication of Pre-selected Focal Spot and Target Material - Alternative Standard  52

3.3.7   Dedicated Buckys and Spot Compression Paddles. 53

3.3.8   Unit Accreditation. 53

3.3.9   Subsequent Use of X-Ray Units that Failed during the Inspection. 53

4.      SYSTEM PERFORMANCE TESTS. 55

4.1       General 55

4.1.1   ^+Equipment Measurements which Result in Borderline Values. 55

4.1.2   Retention of MQSA Inspection Test Films. 55

4.1.3   Unusual or Unexplainable Errors. 56

4.1.4   Situations without Corresponding Questions in the Software. 56

4.2       Phantom Image Quality Evaluation. 57

4.2.1   ^+Phantom Image Scoring - General Procedure. 60

4.2.2   Phantom Scoring Video. 61

4.2.3   Phantom Images Exposed in a Fully Automatic Mode - Assigning a kVp. 61

4.3       The Sensitometric Technique for Evaluation of Processing (STEP) Test 62

4.3.1   ^+The STEP Test – General Guidance. 64

4.3.2   Step Reference Number for the Control Film.. 64

4.3.3   Control Film Used for the STEP Test 65

4.3.4   Update on Film Processor Testing. 65

4.3.5   STEP (Test) Field Calibration Protocol 66

4.3.6   Processing Cycle and the STEP Test 67

4.4       The Darkroom Fog Test 68

4.4.1   ^+Darkroom Fog - Daylight System Inspection Issues. 70

5.      QUALITY ASSURANCE (QA) PROGRAM... 71

5.1       Background. 71

5.2       Procedure. 72

5.3       ^+Further Details. 72

5.3.1   General 72

5.3.2   Specific Personnel Responsibilities. 73

5.3.3   Consumer Complaint Mechanism – Compliance Criteria. 74

5.3.4   Procedures for Infection Control - Compliance Criteria. 74

5.3.5   Dealing with Breast Implant Patients - Compliance Criteria. 74

5.3.6   Consumer Complaint Mechanism – Handling Complaints about a Facility. 74

5.3.7   Facility Complaints Regarding MQSA Inspectors - Resolution Process. 75

6.      QUALITY CONTROL (QC) RECORDS. 77

6.0       General 77

6.0.1   ^+QC Records Retention Requirement for Replaced Equipment 77

6.0.2   Documentation of the Required Screen-Film QC Tests. 78

6.0.3   Reviewing QA/QC Records for Retired Equipment 79

6.1       Processor Performance QC (Daily) 80

6.1.1   ^+Charting of Quality Control (QC) Test Results. 81

6.1.2   Performing the Daily Processor QC when the Sensitometer is not Available - Alternative Standard  81

6.1.3   Performing the Daily Processor QC when the Densitometer is not Available. 82

6.1.4   Situations Warranting Re-establishment of Processor Operating Levels. 82

6.1.5   Facility Actions while Establishing/Re-establishing Processor Operating Levels. 82

6.1.6   Time Constraints on the 5-day Averaging Period for Establishing/Re-establishing Processor Operating Levels. 83

6.1.7   Performing Daily QC on the Back-up Processor (General Purpose or Dedicated for Mammography) 83

6.1.8   Performing Daily QC on Mammography Processors that are also Used for Copying Mammograms and for Laser Films that are Used in Full Field Digital Mammography (FFDM) 84

6.1.9   Performing the Daily QC Tests on a Processor Used Only for Duplication of Mammograms  84

6.1.10 Performing the Daily Processor QC Tests on Days when Mammograms are Performed but not Processed. 84

6.1.11 Performing Processor QC Using Phantom Image Measurements. 84

6.1.12 Preset Scanning Densitometers. 84

6.1.13 Automatic Densitometers and Saving Data. 85

6.1.14 Sensitometer Calibration. 85

6.2       Fixer Retention QC (Quarterly) 85

6.2.1   ^+Fixer Retention QC Records. 85

6.3       Phantom Image QC (Weekly) 85

6.3.1   ^+Phantom Image QC Records - Operating Levels. 86

6.3.2   Phantom Image QC Film.. 87

6.3.3   Reviewing Phantom Image QC Records. 87

6.3.4   Test Conditions for the Weekly Phantom Image. 87

6.3.5   Monitoring of the Weekly Phantom QC at a Facility with Multiple Processors and Multiple X-Ray Units. 88

6.3.6   Facility Actions if and when the Optical Density (OD) for the Weekly Phantom Test Falls Outside Action Limits. 88

6.3.7   Conducting the Weekly Phantom Image Test for Mammography Facilities Operating Intermittently - Alternative Standard. 89

6.3.8   Facility Use of a Cracked Breast Phantom.. 90

6.3.9   Phantom Modifications. 90

6.3.10 Using the Phantom Image QC Test as a Substitute for Sensitometry. 90

6.3.11 Performance Verification Test for Mobile Mammography Units. 91

6.4       Compression QC (Semi-annually) 91

6.4.1   ^+Maintaining Compression. 92

6.5       Repeat Analysis QC (Quarterly) 92

6.5.1   ^+Repeat Analysis in a JCAHO Facility. 93

6.6       Screen-Film Contact QC (Semi-annually) 93

6.6.1   ^+Screen-Film Contact QC - Procedures Manual 94

6.6.2   S/F Contact - Test Conditions and Pass/Fail Criteria. 94

6.7       Darkroom Fog QC (Semi-annually) 94

6.7.1   ^+Darkroom Fog QC – Daylight System Issues. 95

6.8       Digital Mammography QC.. 95

6.8.1   ^+Evaluation Procedures for FFDM Systems (APPENDIX 2) 96

6.8.2   Facility’s Use of Printers and Monitors not Specifically Approved as Part of its FFDM Unit 96

7.      Annual PHYSICS SURVEY REPORT.. 97

7.1       Report Contents. 97

7.2       Facility Response to Medical Physicist’s Observations. 98

7.3       Survey Report Screens. 98

7.3.A   Survey Report - Information Screen. 98

7.3.B   Survey Questions (Screens 3.10.1 & 3.10.2) 99

7.4       ^+Further Details. 103

7.4.1   Data Entry - Information Tab (Screen 3.10) 103

7.4.2   Survey Report Availability for FFDM Systems. 104

7.4.3   Direct Supervision & Signature on the Survey or Mammography Equipment Evaluation (MEE) Report 104

7.4.4   Extension of the 14 Month Limit for the Medical Physicist Survey. 104

7.4.5   Multiple Dates for the Medical Physicist Survey. 105

7.4.6   If the Survey Shows Mistakes or Contradictions. 105

7.4.7   Citation Levels Associated with Report Status and Date(s) 105

7.4.8   Using BR12 Rather than the RMI 156 Phantom for Dose Calculations. 106

7.4.9   HVL Measurement 106

7.4.10 Focal Spot Condition (System Resolution) Test 107

7.4.11 AEC Performance – Clarification of Terms. 107

7.4.12 AEC Performance – Meeting the Annual Survey Test Requirements. 108

7.4.13 AEC Performance – Testing Units with Multiple Detectors. 109

7.4.14 AEC Performance – Testing with Different Image Receptor Sizes. 109

7.4.15 AEC Performance – Testing outside the 2-6 cm Range. 110

7.4.16 Testing of AEC Modes not Used Clinically. 110

7.4.17 AEC Reproducibility –Units with Multiple Detectors and AEC Modes. 110

7.4.18 Collimation Test Scope. 110

7.4.19 Artifact Test Scope. 110

7.4.20 Artifact Test for Daylight Processing Systems. 112

7.4.21 KVp Values Used during Testing. 112

7.4.22 Screen Speed Uniformity – Cassettes with Different Speeds. 113

7.4.23 Decompression Test – Alternative Standard. 113

7.4.24 Scope of the Survey Tests. 114

7.4.25 Use of Test Results. 115

7.4.26 Facility Actions when the AEC Fails the Medical Physicist Testing. 116

8.      MAMMOGRAPHY EQUIPMENT EVALUATIONS (MEE). 118

8.1       General 118

8.1.A   Newly Installed or Reassembled X-ray Unit 118

8.1.B   Newly Installed or Reassembled Processor 118

8.2       Major Repairs. 119

8.3       Data Entry. 119

8.4       ^+Further Details. 120

8.4.1   General 120

8.4.2   AEC Performance Testing for the MEE – Scope and Action Limits. 120

8.4.3   AEC Performance Testing during the MEE outside the 2-6 cm Range. 121

8.4.4   Validity of the kVp(s) Used in MEE Testing. 121

8.4.5   Motion of the Tube-Image Receptor Assembly. 122

8.4.6   Manufacturer’s Software Modification of the AEC – Alternative Standard. 122

8.4.7   Conducting the Mammography Equipment Evaluation after a Software Upgrade under Medical Physicist Oversight – Alternative Standard # 6. 122

8.4.8   ^+Moving a Unit within a Facility. 124

9.      PERSONNEL QUALIFICATIONS. 129

9.1       All Personnel Categories. 129

9.1.1   Maintenance of Personnel Records. 130

9.1.2   Letters from Approved Certifying Boards. 130

9.1.3   Direct Supervision Issues. 131

9.1.4   Past or Part Time Employees. 131

9.1.5   Credits for Mammography Personnel Teaching a Course/Reading or Writing Articles  132

9.1.6   Criteria for Accepting Training/CME/CEU Certificates. 132

9.1.7   Examples of New Mammographic Modalities. 133

9.2       Interpreting Physician (Screen 3.11.1) 134

9.2.1   ^+Qualification Requirements - Interpreting Physicians. 137

9.2.2   Direct Supervision for Interpreting Physicians. 139

9.2.3   Applicability of the Requirement for 8 Hours of Training in Each Mammographic Modality  139

9.2.4   Requirements for the Content of the FFDM Training. 140

9.2.5   Training/Experience in Stereotactic Biopsy Systems with Digital Image Receptors Prior to 4/28/99  140

9.3       Radiologic Technologist (Screen 3.11.2) 141

9.3.1   ^+Qualification Requirements - Radiologic Technologists. 144

9.3.2   Direct Supervision for Radiologic Technologists. 146

9.3.3   The ARRT (M) Certificate. 146

9.3.4   Applicability of the Requirement for 8 Hours of Training in Each Mammographic Modality  147

9.3.5   Requirements for the Content of the FFDM Training. 147

9.3.6   Training/Experience in Stereotactic Biopsy Systems with Digital Image Receptors Prior to 4/28/99  148

9.3.7   CME/CEU Credit for MQSA Teleconference (Live or Tape Viewing)